bioRxiv Science⌕ Search

Biology subjects

Valencia, C. H.

Publications and source records attributed to Valencia, C. H..

3 recordsLinked to original sources

Developmental IL7/IL7R signaling in fetal resident tissue macrophages regulates adaptive responses to liver injury

Resident tissue macrophages (RTMs) originate from multiple fetal hematopoietic waves and seed organs during the prenatal window where they acquire tissue-specific homeostatic functions. Several growth factors within the fetal niche are required for RTM development, but knowledge of how these signals program tissue-specific RTM survival, identity, and function during the prenatal window is limited. Here, we investigated the functional role of developmental IL7/IL7R signaling on fetal RTM survival and function. IL7 deficiency impaired neonatal RTM establishment, similar to IL7R deficiency, and IL7 was broadly expressed in fetal tissues and co-localized with IL7R+ macrophages. IL7/IL7R signaling regulated cell cycle, apoptotic, and inflammatory transcriptional pathways and activated phospho-AKT signaling in fetal liver myeloid cells. IL7R deletion impaired proliferation of fetal liver monocyte precursors and increased fetal liver macrophage apoptosis. Specific Cre-mediated IL7R deletion in fetal definitive HSC-derived, but not EMP- derived, macrophages caused irrecoverable postnatal loss of IL7R-expressing macrophages in specific tissues, including the liver, demonstrating a specific temporal requirement for IL7R expression during fetal myelopoiesis. Prenatal IL7R blockade subsequently impaired adaptive responses to chronic fibrotic liver injury in adulthood, associated with increased monocyte infiltration and upregulation of pro-inflammatory signaling pathways. These findings redefine IL7 as a developmental myeloid niche factor and demonstrate that IL7/IL7R signaling is co-opted during fetal development to imprint durable RTM programs that shape postnatal tissue immunity and adaptive responses to injury.

immunology↗

Loss of short-form Ron promotes B and T cell cooperation to prevent outgrowth of breast cancer bone metastasis

While immunotherapy has great potential to eradicate tumors, success in metastatic breast cancer is limited. Bone metastasis, the most common site for breast cancer metastasis, has been associated with weakened anti-tumor immunity, both in the bone and in other metastatic sites. Additional strategies promoting anti-tumor immunity are needed. Using the MMTV-PyMT intratibial model of breast cancer bone metastasis, we discovered that deletion of host short-form Ron (Ron SF-/-) protected against bone metastatic outgrowth by promoting strong infiltration of lymphocytes, including B cells, into tumors at the micrometastasis stage. Transcriptionally, Ron SF-/- B cells were more active and inflammatory compared to wildtype. Elimination of mature B cells (JH-/-) rescued tumor growth in Ron SF-/- mice, indicating that mature B cells were necessary for anti-tumor immunity and protection against bone metastasis. In Ron SF-/- hosts, T follicular helper (Tfh) cells were abundant in tumor-enriched regions of bone, suggesting interactions between B and T cells. B-T cell cooperation was further supported by attenuation of CD4 and CD8 T cell tumor infiltration in Ron SF-/-JH-/- hosts and, conversely, diminished B cell tumor infiltration and rescue of tumor growth in Ron SF-/- hosts lacking CD4 or CD8 T cells. B cells were not required to protect Ron SF-/- mice from lung metastasis, indicating a tissue-dependent anti-tumor role for B cells. These data support a positive feedback loop between B and T cells regulated by SF-Ron and reveal the anti-tumor potential of B cells in the bone.

cancer biology↗

Prenatal inflammation perturbs fetal hematopoietic development and causes persistent changes to postnatal immunity

Adult hematopoietic stem and progenitor cells (HSPCs) respond directly to inflammation and infection, resulting in both acute and persistent changes to quiescence, mobilization, and differentiation. Here we show that fetal HSPCs respond to prenatal inflammation in utero, and that the fetal response shapes postnatal hematopoiesis and immunity. Heterogenous fetal HSPCs showed divergent responses to maternal immune activation (MIA), including changes in quiescence, expansion, and lineage-biased output. Single cell transcriptomic analysis of fetal HSPCs in response to MIA revealed specific upregulation of inflammatory gene profiles in discrete, transient HSC populations, that propagated expansion of lymphoid-biased progenitors. Beyond fetal development, MIA caused the inappropriate expansion and persistence of fetal lymphoid-biased progenitors postnatally, concomitant with increased cellularity and hyperresponsiveness of fetal-derived innate-like lymphocytes. Our investigation demonstrates how inflammation in utero can direct the trajectory of output and function of fetal-derived immune cells by reshaping fetal HSC establishment.

cell biology↗